Is the predictive value of systemic immune-inflammation index superior to traditional markers in ST-elevation myocardial infarction patients?
Yükleniyor...
Dosyalar
Tarih
2023
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Lippincott Williams & Wilkins
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
We read with great interest the recently published article ‘Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction’ by Öcal et al [1]. In their valuable, well designed, and presented research, the authors argue that the systemic immune-inflammation index (SII) is superior to traditional markers such as neutrophil-to-lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) in predicting in-hospital adverse events in patients with ST-elevation myocardial infarction (STEMI) and they also claim that the discriminative value of SII in predicting in-hospital mortality in STEMI patients is higher than NLR; however, when the whole article is evaluated, we think that some methodological and literary issues should be reviewed by the authors.
Açıklama
Anahtar Kelimeler
ST-elevation Myocardial Infarction (STEMI), NLR, PLR
Kaynak
Coronary Artery Disease
WoS Q Değeri
Q3
Scopus Q Değeri
Q3
Cilt
34
Sayı
4
Künye
Toprak, K., Kaplangöray, M., Memioglu, T., & İnanir, M. (2023). Is the predictive value of systemic immune-inflammation index superior to traditional markers in ST-elevation myocardial infarction patients?. Coronary Artery Disease, 34(4), 281-281.
